Use Options For a Chance To Buy CLVS at a 48% Discount
October 02, 2015 at 11:44 AM EDT
Looking back to 86 days ago, Clovis Oncology Inc (CLVS) priced a 3,525,641 share secondary stock offering at $78.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time and based on early trading on Friday, the stock is now 14.2% higher than the offering price..